Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.

Grody WW, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Fang CY, Cantor RM, Novak JM, Bass HN, Crandall BF.

Am J Hum Genet. 1997 Apr;60(4):935-47.

2.

Cystic fibrosis.

Shulman LP, Elias S.

Clin Perinatol. 2001 Jun;28(2):383-93. Review.

PMID:
11499059
3.

The cost-effectiveness of prenatal carrier screening for cystic fibrosis.

Lieu TA, Watson SE, Washington AE.

Obstet Gynecol. 1994 Dec;84(6):903-12.

PMID:
7970468
4.

Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.

Akerman BR, Natowicz MR, Kaback MM, Loyer M, Campeau E, Gravel RA.

Am J Hum Genet. 1997 May;60(5):1099-106.

5.

Improved detection of CFTR mutations in Southern California Hispanic CF patients.

Wong LJ, Wang J, Zhang YH, Hsu E, Heim RA, Bowman CM, Woo MS.

Hum Mutat. 2001 Oct;18(4):296-307.

PMID:
11668613
6.

Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations.

DeMarchi JM, Beaudet AL, Caskey CT, Richards CS.

Arch Pathol Lab Med. 1994 Jan;118(1):26-32.

PMID:
8285831
7.

Update on population-based preconception and prenatal cystic fibrosis carrier screening.

Nolen AA, Rhoades ED.

J Okla State Med Assoc. 2003 Oct;96(10):482-4. Review.

PMID:
14619603
8.

A novel approach to CFTR mutation testing by pyrosequencing-based assay panels adapted to ethnicities.

Bickmann JK, Kamin W, Wiebel M, Häuser F, Wenzel JJ, Neukirch C, Stuhrmann M, Lackner KJ, Rossmann H.

Clin Chem. 2009 Jun;55(6):1083-91. doi: 10.1373/clinchem.2008.120220. Epub 2009 Apr 16.

9.

Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.

Kaufman DJ, Katsanis SH, Javitt GH, Murphy JA, Scott JA, Hudson KL.

Clin Genet. 2008 Oct;74(4):367-73. doi: 10.1111/j.1399-0004.2008.01070.x. Epub 2008 Aug 12.

PMID:
18700896
10.
11.

The impact of population based screening for carriers of cystic fibrosis.

Bekker H, Denniss G, Modell M, Bobrow M, Marteau T.

J Med Genet. 1994 May;31(5):364-8.

12.

Alport syndrome. Molecular genetic aspects.

Hertz JM.

Dan Med Bull. 2009 Aug;56(3):105-52.

PMID:
19728970
13.

Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.

Henneman L, Bramsen I, van Kempen L, van Acker MB, Pals G, van der Horst HE, Adèr HJ, van der Ploeg HM, ten Kate LP.

Community Genet. 2003;6(1):5-13.

PMID:
12748433
14.

Cystic fibrosis carrier frequencies in populations of African origin.

Padoa C, Goldman A, Jenkins T, Ramsay M.

J Med Genet. 1999 Jan;36(1):41-4.

15.

[Screening for carriers of cystic fibrosis. Result of a pilot study among pregnant women].

Brandt NJ, Schwartz M, Skovby F.

Ugeskr Laeger. 1994 Jun 20;156(25):3751-4, 3757. Danish.

PMID:
8059452
16.

Carrier testing for autosomal-recessive disorders.

Vallance H, Ford J.

Crit Rev Clin Lab Sci. 2003 Aug;40(4):473-97. Review.

PMID:
14582604
17.

Implementing prenatal screening for cystic fibrosis in routine obstetric practice.

Fries MH, Bashford M, Nunes M.

Am J Obstet Gynecol. 2005 Feb;192(2):527-34.

PMID:
15695998
18.

Cystic fibrosis screening.

Shulman LP.

J Midwifery Womens Health. 2005 May-Jun;50(3):205-10. Review.

PMID:
15894998
19.

Mutation analysis of Western Australian families affected by cystic fibrosis.

Goldblatt J, Creegan R, Edkins T, Landau LI, Ryan G, Walpole IR.

Med J Aust. 1995 Jan 2;162(1):12-5.

PMID:
7845290
20.

Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers.

Rowley PT, Loader S, Levenkron JC, Phelps CE.

Am J Prev Med. 1993 Sep-Oct;9(5):261-6.

PMID:
8257614

Supplemental Content

Support Center